Primary Site >> Colorectal Cancer

Gene >> EGFL7

Journal: Genes Chromosomes Cancer. 2008 Sep;47(9):794-802.
Title: Deregulated expression of miR-106a predicts survival in human colon cancer patients.
Author: Diaz, Raquel|Silva, Javier|Garcia, Jose M|Lorenzo, Yolanda|Garcia, Vanesa|Pena, Cristina|Rodriguez, Rufo|Munoz, Concepcion|Garcia, Fernando|Bonilla, Felix|Dominguez, Gemma
PMID: 18521848
Journal: Anticancer Res. 2011 Jun;31(6):2249-54.
Title: Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.
Author: Wu, Fan|Shirahata, Atsushi|Sakuraba, Kazuma|Kitamura, Yohei|Goto, Tetsuhiro|Saito, Mitsuo|Ishibashi, Kazuyoshi|Kigawa, Gaku|Nemoto, Hiroshi|Sanada, Yutaka|Hibi, Kenji
PMID: 21737648
Journal: Int J Biol Markers. 2013 Apr 23;28(1):71-83.
Title: The expression of Egfl7 in human normal tissues and epithelial tumors.
Author: Fan, Chun|Yang, Lian-Yue|Wu, Fan|Tao, Yi-Ming|Liu, Lin-Sen|Zhang, Jin-Fan|He, Ya-Ning|Tang, Li-Li|Chen, Guo-Dong|Guo, Lei
PMID: 23558933
Journal: Oncol Rep. 2013 Oct;30(4):1976-84.
Title: Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
Author: Zhang, Yu|Wang, Xinying|Xu, Binghong|Wang, Baocai|Wang, Zhongqiu|Liang, Yan|Zhou, Jieqiong|Hu, Jingjing|Jiang, Bo
PMID: 23900443
Journal: Asian Pac J Cancer Prev. 2014;15(7):3045-50.
Title: Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
Author: Xu, Han-Feng|Chen, Lei|Liu, Xian-Dong|Zhan, Yun-Hong|Zhang, Hui-Hui|Li, Qing|Wu, Bin
PMID: 24815445
Journal: J Transl Med. 2015 Jan 16;13:10.
Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.
Author: Hansen, Torben Frostrup|Nielsen, Boye Schnack|Jakobsen, Anders|Sorensen, Flemming Brandt
PMID: 25592646
Journal: Sci Rep. 2017 May 24;7(1):2388.
Title: Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.
Author: Hansen, Torben Frostrup|Andersen, Rikke Fredslund|Olsen, Dorte Aalund|Sorensen, Flemming Brandt|Jakobsen, Anders
PMID: 28539619
Journal: Oncologist. 2018 Jun;23(6):654-e58.
Title: Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.
Author: von Pawel, Joachim|Spigel, David R|Ervin, Thomas|Losonczy, Gyorgy|Barlesi, Fabrice|Juhasz, Erzsebet|Anderson, Maria|McCall, Bruce|Wakshull, Eric|Hegde, Priti|Ye, Weilan|Chen, Daniel|Chang, Ilsung|Rhee, Ina|Reck, Martin
PMID: 29438092
Journal: Clin Colorectal Cancer. 2018 Sep;17(3):e471-e488.
Title: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
Author: Hanna, Diana L|Loupakis, Fotios|Yang, Dongyun|Cremolini, Chiara|Schirripa, Marta|Li, Meng|Matsusaka, Satoshi|Berger, Martin D|Miyamoto, Yuji|Zhang, Wu|Ning, Yan|Antoniotti, Carlotta|Salvatore, Lisa|Moran, Miriana|Zeger, Gary|Astrow, Stephanie H|Falcone, A
PMID: 29636300
Journal: J Cell Physiol. 2018 Nov;233(11):8526-8537.
Title: EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Author: Hong, Guoju|Kuek, Vincent|Shi, Jiaxi|Zhou, Lin|Han, Xiaorui|He, Wei|Tickner, Jennifer|Qiu, Heng|Wei, Qiushi|Xu, Jiake
PMID: 29923200